• August Therapeutics has identified Acerbin as the causative agent
responsible for dysgeusia in Pine Nut Syndrome
• Acerbin is being developed as a therapeutic protein to treat eating disorders and obesity-related diseases
Simple solution
• People do not overeat unpalatable food
• Acerbin directly impacts food palatability to reduce hedonic eating, thereby limiting caloric intake